Live Breaking News & Updates on Mutation Agnostic Optogenetic Therapy

Stay updated with breaking news from Mutation agnostic optogenetic therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Nanoscope Therapeutics Announces Presentations at the ARVO Annual Meeting

/PRNewswire/ Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today. ....

United States , Subrata Batabyal , Najam Sharif , Vinitb Mahajan , Samarendra Mohanty , Samuel Barone , Nanoscope Therapeutics Inc , Prnewswire Nanoscope Therapeutics Inc , Professor Of Ophthalmology At Stanford University , Seattle Convention Center , Clinical Development , Global Research , Therapeutics Inc , Multi Characteristic Opsin , Nanoscope Therapeutics , Convention Center , Chief Medical , Test Retest Agreement , Freiburg Visual Acuity Test , Poster Number , Low Vision Performance , Exhibit Hall , Stargardt Disease , Macular Degeneration Treated With , Mutation Agnostic Optogenetic Therapy , Week Results From ,